Oral antivirals may reduce COVID-19 symptoms, progression, transmission, hospitalisation and mortality. We guide on successful deployment for Chief Pharmacists.


Outside trials and if nMABs are contraindicated, availability is via NHSE Covid Medicines Delivery Units (CMDUs). Use our deployment principles and checklist.

Treatments in CMDUs

Chief Pharmacists may need to oversee and manage prescription and supply of nMABs and oral antivirals in CMDUs. Use our framework and resources to help.
Three models exist for the supply and administration of COVID-19 treatments through CMDUs. We guide through the risks and mitigations associated with each.